Bioglyco ApS: Financial statements 2023
CVR: 39676664
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Bioglyco ApS (CVR 39676664) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,625 and a net result of DKK -2,625 compared with DKK -2,312 the year before. Equity in the 2023 report amounted to DKK 24,067. The solvency ratio was 67.5%.
- Gross Profit
- DKK -2,625
- Profit/Loss
- DKK -2,625
- Equity
- DKK 24,067
- Total Assets
- DKK 35,644
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -3 t. | -3 t. | 24 t. | - |
| 2022 | - | -2 t. | -2 t. | 27 t. | - |
| 2021 | - | -2 t. | -2 t. | 4 t. | - |
| 2020 | - | -2 t. | -2 t. | 7 t. | - |
| 2019 | - | -6 t. | -6 t. | 9 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Bioglyco ApS
Bioglyco ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Bioglyco IVS. The management consists of Giuseppe Palmisano. The company is owned by Giuseppe Palmisano. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK -2,625 the year before. Equity in the 2025 report amounted to DKK 17,692.